Tags: Drug.

Mavrilimumab is a human monoclonal antibody designed for the treatment of rheumatoid arthritis.Mavrilimumab was discovered as CAM-3001 by Cambridge Antibody Technology and is being developed by MedImmune Inc.

ATC prefix
none
CAS number
1085337-57-0
FDA UNII code
1158JD1P9A

Loading...

This page contains content from the copyrighted Wikipedia article "Mavrilimumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.